Azienda Ospedaliera di Perugia

Quick facts

Marketed products

• Aspirin plus clopidogrel

Phase 3 pipeline

• Placebo, Palonosetron, Dexamethasone · Oncology (supportive care)
  This is a combination regimen using palonosetron (a 5-HT3 antagonist) and dexamethasone (a corticosteroid) to prevent chemotherapy-induced nausea and vomiting, with placebo as a control arm.

Phase 1 pipeline

• AntiPD1

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Azienda Ospedaliera di Perugia portfolio CI brief
• Azienda Ospedaliera di Perugia pipeline updates RSS